1,525
Views
10
CrossRef citations to date
0
Altmetric
Editorial

How to utilize academic research efforts in cancer drug discovery

Pages 331-334 | Received 21 Sep 2018, Accepted 11 Feb 2019, Published online: 20 Feb 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Nehal A. Hamdy, Mardia T. El Sayed, Hoda A. R. Hussein, Marwa M. Mounier & Manal M. Anwar. (2023) Synthesis of novel heterocyclic compounds bearing tetralin moiety of potential anticancer activity targeting the intrinsic apoptotic pathway. Synthetic Communications 53:4, pages 298-315.
Read now
Federico Riu, Roberta Ibba, Stefano Zoroddu, Simona Sestito, Michele Lai, Sandra Piras, Luca Sanna, Valentina Bordoni, Luigi Bagella & Antonio Carta. (2022) Design, synthesis, and biological screening of a series of 4′-fluoro-benzotriazole-acrylonitrile derivatives as microtubule-destabilising agents (MDAs). Journal of Enzyme Inhibition and Medicinal Chemistry 37:1, pages 2223-2240.
Read now
Mohamed R. Shaaban, Thoraya A. Farghaly & Amani M. R. Alsaedi. (2022) Synthesis, Antimicrobial and Anticancer Evaluations of Novel Thiazoles Incorporated Diphenyl Sulfone Moiety. Polycyclic Aromatic Compounds 42:5, pages 2521-2537.
Read now

Articles from other publishers (7)

Piotr Ozieranski, Hiroaki Saito, Emily Rickard, Shai Mulinari & Akihiko Ozaki. (2023) International comparison of pharmaceutical industry payment disclosures in the UK and Japan: implications for self-regulation, public regulation, and transparency. Globalization and Health 19:1.
Crossref
El-Mahdi Ourhzif, Alessandra Ricelli, Venturina Stagni, Angela Cirigliano, Teresa Rinaldi, Latifa Bouissane, Luciano Saso, Pierre Chalard, Yves Troin, Mostafa Khouili & Mohamed Akssira. (2022) Antifungal and Cytotoxic Activity of Diterpenes and Bisnorsesquiterpenoides from the Latex of Euphorbia resinifera Berg. Molecules 27:16, pages 5234.
Crossref
Stefano Zoroddu, Paola Corona, Luca Sanna, Federica Borghi, Valentina Bordoni, Battistina Asproni, Gerard A. Pinna, Luigi Bagella & Gabriele Murineddu. (2022) Novel 1,3,4-oxadiazole chalcogen analogues: Synthesis and cytotoxic activity. European Journal of Medicinal Chemistry 238, pages 114440.
Crossref
Abdoullah Bimoussa, Ali Oubella, Az‐eddine El Mansouri, Mourad Fawzi, Yassine Laamari, Abdelouahed Auhmani, My Youssef Ait Itto, Hamid Morjani & Aziz Auhmani. (2022) Synthesis and Biological Evaluation of Novel Thiazole Analogs with Both Anti‐Proliferative and Mechanistic Analyses and Molecular Docking Studies. ChemistrySelect 7:11.
Crossref
Khodayar Gholivand, Mohammad Faraghi, Nasrin Fallah, Mohammad Satari & Mahsa Pooyan. (2022) New phosphoramides containing imidazolidine moiety as anticancer agents: An experimental and computational study. Bioorganic Chemistry 120, pages 105617.
Crossref
Abdoullah Bimoussa, Ali Oubella, Yassine Laamari, Mourad Fawzi, Mouhi Eddine Hachim, My Youssef Ait Itto, Hamid Morjani, El Mostafa Ketatni, Olivier Mentre & Aziz Auhmani. (2021) Hybrid of the 1,2,3‐triazole nucleus and sesquiterpene skeleton as a potential antitumor agent: Hemisynthesis, molecular structure, Hirshfeld surface analysis, density functional theory, and in vitro cytotoxic and apoptotic effects. Journal of Heterocyclic Chemistry 58:12, pages 2334-2347.
Crossref
Mahsa Ansari, Mohammad Shokrzadeh, Saeed Karima, Shima Rajaei, Marjan Fallah, Nasrin Ghassemi-Barghi, Majid Ghasemian & Saeed Emami. (2020) New thiazole-2(3H)-thiones containing 4-(3,4,5-trimethoxyphenyl) moiety as anticancer agents. European Journal of Medicinal Chemistry 185, pages 111784.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.